Business Description
Korea Arlico Pharm Co Ltd
ISIN : KR7260660006
Compare
Compare
Traded in other countries / regions
260660.Korea IPO Date
2018-02-12Description
Korea Arlico Pharm Co Ltd is engaged in the business of manufacturing and selling pharmaceuticals products. The company offers products in the area of the circulatory system, antiplatelet, muscle relaxants, diabetes, antibiotic and chemotherapy, allergy and respiratory disease, ointment, vitamin and health supplements, digestive system, and metabolic disease. It provides products in various forms such as tablets, capsules, gel, and cream.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.37 | |||||
| Equity-to-Asset | 0.5 | |||||
| Debt-to-Equity | 0.58 | |||||
| Debt-to-EBITDA | -15.55 | |||||
| Piotroski F-Score | 1/9 | |||||
| Altman Z-Score | 1.68 | |||||
| Beneish M-Score | -2.47 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 31.2 | |||||
| 3-Year EBITDA Growth Rate | 6.1 | |||||
| 3-Year EPS without NRI Growth Rate | -35.8 | |||||
| 3-Year FCF Growth Rate | -63.5 | |||||
| 3-Year Book Growth Rate | 3.2 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 48.42 | |||||
| 9-Day RSI | 43.17 | |||||
| 14-Day RSI | 41.38 | |||||
| 6-1 Month Momentum % | -19.8 | |||||
| 12-1 Month Momentum % | -34.77 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.1 | |||||
| Quick Ratio | 0.64 | |||||
| Cash Ratio | 0.26 | |||||
| Days Inventory | 126.53 | |||||
| Days Sales Outstanding | 46.11 | |||||
| Days Payable | 26.03 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 3.45 | |||||
| 3-Year Dividend Growth Rate | 27 | |||||
| Forward Dividend Yield % | 3.45 | |||||
| 5-Year Yield-on-Cost % | 3.45 | |||||
| 3-Year Average Share Buyback Ratio | -1.5 | |||||
| Shareholder Yield % | -15.11 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 54.2 | |||||
| Operating Margin % | -6.19 | |||||
| Net Margin % | -4.96 | |||||
| FCF Margin % | -11.4 | |||||
| ROE % | -9.97 | |||||
| ROA % | -5.3 | |||||
| ROIC % | -6.77 | |||||
| 3-Year ROIIC % | -8.79 | |||||
| ROC (Joel Greenblatt) % | -10.21 | |||||
| ROCE % | -8.94 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.33 | |||||
| PB Ratio | 0.69 | |||||
| Price-to-Tangible-Book | 0.76 | |||||
| EV-to-EBIT | -9.59 | |||||
| EV-to-EBITDA | -28.52 | |||||
| EV-to-Revenue | 0.48 | |||||
| EV-to-FCF | -4.24 | |||||
| Earnings Yield (Greenblatt) % | -10.43 | |||||
| FCF Yield % | -35.73 | |||||
| Forward Rate of Return (Yacktman) % | -12.43 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Korea Arlico Pharm Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 178,826.862 | ||
| EPS (TTM) (â‚©) | -590.499 | ||
| Beta | 0.67 | ||
| Volatility % | 12.85 | ||
| 14-Day RSI | 41.38 | ||
| 14-Day ATR (â‚©) | 171.801268 | ||
| 20-Day SMA (â‚©) | 3864.75 | ||
| 12-1 Month Momentum % | -34.77 | ||
| 52-Week Range (â‚©) | 3670 - 6330 | ||
| Shares Outstanding (Mil) | 15.01 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Korea Arlico Pharm Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Korea Arlico Pharm Co Ltd Stock Events
| Event | Date | Price(â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
Korea Arlico Pharm Co Ltd Frequently Asked Questions
What is Korea Arlico Pharm Co Ltd(XKRX:260660)'s stock price today?
The current price of XKRX:260660 is â‚©3800.00. The 52 week high of XKRX:260660 is â‚©6330.00 and 52 week low is â‚©3670.00.
When is next earnings date of Korea Arlico Pharm Co Ltd(XKRX:260660)?
The next earnings date of Korea Arlico Pharm Co Ltd(XKRX:260660) is .
Does Korea Arlico Pharm Co Ltd(XKRX:260660) pay dividends? If so, how much?
The Dividend Yield %  of Korea Arlico Pharm Co Ltd(XKRX:260660) is 3.45% (As of Today), Highest Dividend Payout Ratio of Korea Arlico Pharm Co Ltd(XKRX:260660) was 1.25. The lowest was 0.1. And the median was 0.21. The  Forward Dividend Yield % of Korea Arlico Pharm Co Ltd(XKRX:260660) is 3.45%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers